Tetrapropylammonium

Tetrapropylammonium

SCHEMBL330672

CCC[N+](CCC)(CCC)CCC.Cc1ccc(S(=O)(=O)[O-])cc1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CHRM1CHRM2CHRM3CHRM4CHRM5SLC6A2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Tetrapropylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.53
CYP2C9 P11712 3/20 0.53
CYP2C19 P33261 3/20 0.53
KCNH2 Q12809 2/20 0.53
LMNA P02545 2/20 0.53
TSHR P16473 1/20 0.53
HTT P42858 1/20 0.53
HIF1A Q16665 1/20 0.53
CYP3A4 P08684 3/20 0.47
MAPK1 P28482 1/20 0.47
THPO P40225 1/20 0.47
GAA P10253 2/20 0.45
ALDH1A1 P00352 4/20 0.44
MCHR1 Q99705 1/20 0.42
CA12 O43570 2/20 0.42
CA2 P00918 2/20 0.42
CA9 Q16790 2/20 0.42
CA1 P00915 1/20 0.42
CA3 P07451 1/20 0.42
CA6 P23280 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL157620 0.89 LMNA (0.61) CYP2D6CYP2C9CYP2C19KCNH2LMNA
Tetrabuthylammonium SCHEMBL9450288 0.87 LMNA (0.60) CYP2D6CYP2C9CYP2C19KCNH2LMNA
SCHEMBL330553 0.87 KCNH2 (0.67) CYP2D6CYP2C9CYP2C19KCNH2LMNA
SCHEMBL6913604 0.87 KCNH2 (0.67) CYP2D6CYP2C9CYP2C19KCNH2LMNA
Tetrahexylammonium SCHEMBL1818038 0.87 KCNH2 (0.67) CYP2D6CYP2C9CYP2C19KCNH2LMNA
SCHEMBL329839 0.87 KCNH2 (0.67) CYP2D6CYP2C9CYP2C19KCNH2LMNA
SCHEMBL331346 0.86 KCNH2 (0.66) CYP2D6CYP2C9CYP2C19KCNH2LMNA
SCHEMBL9619329 0.86 KCNH2 (0.66) CYP2D6CYP2C9CYP2C19KCNH2LMNA
Tetrapropylammonium SCHEMBL332359 0.85 PSIP1 (0.47) CYP2D6CYP2C9CYP2C19KCNH2LMNA
SCHEMBL28368039 0.84 LMNA (0.48) CYP2D6CYP2C9CYP2C19KCNH2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3231790-B1 METHOD FOR PRODUCING CATIONIC LIPID NOF CORP (JP) 2019-11-06 EP disclosed
EP-2295484-B1 POLYMERIZABLE COMPOSITION FOR POLYTHIOURETHANE OPTICAL MATERIAL, POLYTHIOURETHANE OPTICAL MATERIAL OBTAINED FROM SAME POLYMERIZABLE COMPOSITION, AND POLYMERIZATION CATALYST FOR POLYTHIOURETHANE OPTICAL MATERIAL MITSUI CHEMICALS INC (JP) 2018-01-17 EP disclosed
US-9834502-B2 Method for producing cationic lipid NOF CORPORATION (JP) 2017-12-05 US disclosed
EP-2407498-B1 Polymerizable composition for polythiourethane optical material, polythiourethane optical material obtained from the polymerizable composition, and polymerization catalyst for polythiourethane optical material MITSUI CHEMICALS INC (JP) 2017-11-15 EP disclosed
EP-3231790-A1 METHOD FOR PRODUCING CATIONIC LIPID NOF Corporation (JP) 2017-10-18 EP disclosed
US-20170275242-A1 METHOD FOR PRODUCING CATIONIC LIPID NOF CORPORATION (JP) 2017-09-28 US disclosed
US-8304507-B2 Polymerizable composition for polythiourethane optical material, polythiourethane optical material obtained from the polymerizable composition, and polymerization catalyst for polythiourethane optical material MITSUI CHEMICALS, INC. (JP) 2012-11-06 US disclosed
EP-2407498-A2 Polymerizable composition for polythiourethane optical material, polythiourethane optical material obtained from the polymerizable composition, and polymerization catalyst for polythiourethane optical material Mitsui Chemicals, Inc. (JP) 2012-01-18 EP disclosed
US-20110112269-A1 POLYMERIZABLE COMPOSITION FOR POLYTHIOURETHANE OPTICAL MATERIAL, POLYTHIOURETHANE OPTICAL MATERIAL OBTAINED FROM THE POLYMERIZABLE COMPOSITION, AND POLYMERIZATION CATALYST FOR POLYTHIOURETHANE OPTICAL MATERIAL MITSUI CHEMICALS, INC. (JP) 2011-05-12 US disclosed
EP-2295484-A1 POLYMERIZABLE COMPOSITION FOR POLYTHIOURETHANE OPTICAL MATERIAL, POLYTHIOURETHANE OPTICAL MATERIAL OBTAINED FROM SAME POLYMERIZABLE COMPOSITION, AND POLYMERIZATION CATALYST FOR POLYTHIOURETHANE OPTICAL MATERIAL Mitsui Chemicals, Inc. (JP) 2011-03-16 EP disclosed
US-7128976-B2 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2006-10-31 US disclosed
US-7026406-B1 Syndiotactic styrene polymers and process for the production thereof NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2006-04-11 US disclosed
EP-0736574-B1 Thermoplastic resin composition comprising carbonate and acrylic resin GEN ELECTRIC (US) 2004-06-02 EP disclosed
US-20030091838-A1 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2003-05-15 US disclosed
EP-1283221-A1 SYNDIOTACTIC STYRENE POLYMERS AND PROCESS FOR THE PRODUCTION THEREOF National Institute of Advanced Industrial Science and Technology (JP) 2003-02-12 EP disclosed
US-6103827-A A TRANSPARENT THERMOPLASTIC RESIN BLENDS GENERAL ELECTRIC COMPANY (US) 2000-08-15 US disclosed
US-5883194-A RADIATION TRANSPARENT THERMOPLASTIC RESINS OF CARBONATE AND ESTER BLENDS WITH ACRYLATE RESINS AND CATALYSTS GENERAL ELECTRIC COMPANY (US) 1999-03-16 US disclosed
EP-0736574-A2 Thermoplastic resin composition comprising carbonate and acrylic resin GENERAL ELECTRIC COMPANY (US) 1996-10-09 EP disclosed
US-5108558-A PROCESS FOR THE ELECTROREDUCTION OF AROMATIC CARBOXYLIC ACIDS MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1992-04-28 US disclosed
US-4414079-A QUATERNARY AMMONIUM OR PHOSPHANIUM PHASE TRANSFER CATALYST ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1983-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275242-A1 METHOD FOR PRODUCING CATIONIC LIPID LIPA, LIPC, CETP CYP2D6 3644/4885CYP2C9 1357/4885CYP2C19 1973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.